Blood Collection for sampling plays a vital role in the efficiency of patient treatment in hospitals, and diagnostic centers around the world. Blood sample collection procedure includes a chain of events, and every portion of this sequence is highly important to maintain high-quality clinical results. Earlier, capillary blood collection was specifically used to obtain blood from infants for genetic screening. However, capillary blood testing is also recommended for old age patients, burn victims, patients with damaged veins, patients with arms in casts, chemotherapy and obese patients.
Growing demand for diagnosis of chronic diseases, rising prevalence of diabetes, and increasing geriatric population are also fueling the market growth.

The global Capillary Blood Collection Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Capillary Blood Collection Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Capillary Blood Collection Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Capillary Blood Collection Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Capillary Blood Collection Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
F. Hoffmann-La Roche
Danaher Corporation
Abbott Laboratories
Novo Nordisk
Becton Dickinson and Company
Medtronic
B. Braun Melsungen
Thermo Fisher Scientific
Terumo Corporation
Ypsomed Holding
HTL-STREFA
Sarstedt

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Collector
Lancets
Warming Devices
Others

Segment by Application
Hospitals
Clinics
Other